Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fluval AB-like influenza vaccine
- Development stage
- Preclinical
- Lead developer
- Fluart Innovative Vaccines
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Fluval AB-like influenza vaccine (code name FAB-9011) is a trivalent seasonal influenza virus vaccine developed as an investigational medicinal product. It is designed to provide immunization against three strains of the seasonal influenza virus. The product has been referenced in clinical trial documentation and appears to be related to the Fluval line of vaccines, which are used for prophylaxis against seasonal flu. The mechanism of action is typical for inactivated or subunit influenza vaccines, which stimulate an immune response by presenting viral antigens to the host immune system, thereby conferring protection against future infection by those strains[2].
- Other names
- fluval ab-like influenza vaccine
02
Targets
HA0 (Influenza B virus hemagglutinin)
Beyond the preview
Go deeper on Fluval AB-like influenza vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fluval AB-like influenza vaccine.